Acadian Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History

Acadian Asset Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-421,205	Closed	-$6.86M	–	1524
2014 Q4	$6.86M	Sell	421,205 -752,538	-64%	-$13.8M	0.03%	348
2014 Q3	$25.9M	Sell	1,173,743 -85,506	-7%	-$1.75M	0.13%	179
2014 Q2	$25.3M	Hold	1,259,249	–	–	0.12%	181
2014 Q1	$23.4M	Buy	1,259,249 +12,440	+1%	+$171K	0.12%	163
2013 Q4	$12.6M	Buy	1,246,809 +182,658	+17%	+$2.21M	0.07%	222
2013 Q3	$13.7M	Buy	1,064,151 +541,392	+104%	+$6.66M	0.09%	194
2013 Q2	$6.2M	Buy	+522,759	New	+$5.66M	0.04%	271

Other funds holding AMRI

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $911M AUM 0.66% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Acadian Asset Management's AMRI Position: Q1 2015 in Review

Acadian Asset Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 421,205 shares — an estimated $6.86M sold.

Acadian Asset Management first reported a position in AMRI in Q2 2013 and held it in 7 quarters. The position peaked at $25.9M in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

Acadian Asset Management reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
Acadian Asset Management sold 421,205 Albany Molecular Research Inc shares in Q1 2015, an estimated $6.86M.
Acadian Asset Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 7 quarters.
Acadian Asset Management's Albany Molecular Research Inc position peaked at $25.9M in Q3 2014.
131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Acadian Asset Management's 13F filing for Q1 2015, filed 16 Apr 2015.